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Research Article
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Purpose: Tumor necrosis factor-α (TNF-α), secreted by the activated macrophages, may
participate in the onset and progression of colorectal cancer (CRC). The association of
TNF-α –308 G>A (rs1800629) single-nucleotide polymorphism (SNP) with CRC risk has
been investigated by many studies but the results are inconclusive. A trial sequential
meta-analysis was performed for precise estimation of the relationship between TNF-α –308
G>A gene polymorphism with CRC risk.
Methods: Medline (PubMed), EMBASE (Excerpta-Medica) and Google Scholar were mined
for relevant articles. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated
to estimate the significance of association.
Results: The pooled analysis indicated no risk associated with TNF-α –308 G>A SNP and
overall CRC risk in five genetic comparison models, i.e. allelic (A vs. G: P = 0.524; OR =
1.074, 95% CI = 0.863–1.335), homozygous (AA vs. GG: P = 0.489; OR = 1.227, 95% CI =
0.688–2.188), heterozygous (AG vs. GG: P = 0.811; OR = 1.024, 95% CI = 0.843–1.244),
dominant (AA+AG vs. GG: P = 0.630; OR = 1.055, 95% CI = 0.849–1.311) and recessive (AA
vs. AG+GG: P = 0.549; OR = 1.181, 95% CI = 0.686–2.033). Subgroup analysis revealed
that TNF-α –308 G>A SNP is associated with reduced risk of CRC in Asian ethnicity. The
study showed no publication bias.
Conclusions: No association of TNF-α –308 G>A SNP with overall CRC risk was found.
This SNP is likely to be protective against CRC in Asian population when compared with
Caucasian population. Larger prospective-epidemiological studies are warranted to elucidate the roles of TNF-α –308 G>A SNP in the etiology of CRC and to endorse the present
findings.
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Introduction
Approximately 608,000 people lose their life to colorectal cancer (CRC) worldwide [1]. According to the
World Health Organization (WHO), millions of people will suffer from symptomatic as well as approximately the equal number from asymptomatic cases of CRC disease in the next decade.
CRC is a very heterogeneous and polygenic disease at a molecular level. It may be the result of interaction among different factors like environmental and genetic [2]. Early genome-wide association
studies have shown contribution of many new single-nucleotide polymorphisms (SNPs) to increased
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Materials and methods
Search for relevant literature
An online search was done on different databases like PubMed (Medline), Google Scholar and EMBASE covering
all research studies published. The search strings used to retrieve the hits were: Tumor necrosis factor OR tumor
necrosis factor-alpha OR TNFA OR TNFα OR TNF-α OR TNF gene (polymorphism OR variant OR mutation)
AND colorectal cancer susceptibility OR risk (last updated on February 2018). The relevant studies about genetic
association were extracted after perusing their titles and abstracts. The publications suiting the above discussed preset
eligibility criteria were considered for further examination. The references of the retrieved reports were also searched
for additional relevant reports.

Criteria for inclusion and exclusion of studies
To keep the heterogeneity in check and right interpretation of the study, following criteria were followed to include
the published reports in current meta-analysis: (a) only case–control studies assessing association between TNF-α
–308 G>A gene polymorphism and CRC risk, (b) the study must have recruited clearly defined and confirmed CRC
patients and CRC free controls, (d) genotype frequency in cases and the controls should be reported, (e) language of
these studies should be English and (f) should have used statistically relevant data collection and analysis methods.
Additionally, if the case–control studies derived the cases from the same population, the study having larger number
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CRC risk, showing the involvement of multiple low-penetrance genes in CRC incidence [3]. SNPs may contribute to
genomic fragility leading to few critical mutations and eventual CRC onset and progression.
The genetic variants also influence immune response negatively leading to chronic inflammation that may play an
important role not only in CRC progression, but also in metastasis and poor prognosis [4]. Therefore, investigation of
inflammation-related genetic determinants related to CRC might facilitates the preventive and therapeutic strategies
of CRC.
Tumor necrosis factor-α (TNF-α) gene consists of four exons with three intervening introns. It is an important
pro-inflammatory cytokine secreted by activated macrophages and many other immune regulated cell types like lymphocytes, neutrophils, eosinophils, mast cells and endothelial cells [5].
TNF-α also play an important role in apoptosis and angiogenesis by binding to TNFR1 (p55) and TNFR2 (p75)
receptor. This binding induces the expression of adhesion molecules, which further facilitate multiple cell signaling
cascades that lead to inflammation, invasion and metatstatic tumor cells [6].
The relationship of TNF-α associated immune response in the development of CRC is currently a research hotspot
[7]. Recent experimental and clinical studies on the role of TNF-α have revealed that TNF-α plays an important role
in the progression of human CRC by inducing epithelial-to-mesenchymal transformation and subsequently assists
the invasion and metastasis of CRC [8,9]. Previously published reports suggest that variable production of TNF-α is
associated with poor prognosis in CRC patients [10]. Moreover, the levels of plasma cytokines including TNF-α have
been shown to predict the clinical outcomes in patients with advanced CRC [11].
TNF-α production is generally regulated at transcriptional level [12]. The polymorphisms located in the promoter
region of TNF-α gene affects the transcription of TNF-α gene. TNF-α –308 G/A (rs1800629) SNP causing guanine
(G) to adenine (A) substitution is located within regulatory hotspot region and thus influences transcription critically.
The variant allele A causes loss of transcription factors like activator protein-2 binding, inducing high levels of TNF-α
when compared with the wild-type allele G [13]. Early reports have shown that this SNP affects cellular function and
leads to increased levels of TNF-α production [14].
Given the importance of TNF-α in CRC development, common functional polymorphism –308 G>A of TNF-α
gene has been studied extensively. However, the results lack consensus among the populations. The association of –308
G>A polymorphism of TNF-α gene with increased or decreased susceptibility to CRC is still debatable [15–29]. The
prime reasons for the inconsistent results among multiple reports may be the different ethnicity of the population
along with small sample size in various studies. Low sample size seriously curtails the statistical power required to
assess a precise estimate and thus an increase in the sample size may confirm the precise association between TNF-α
–308 G>A gene polymorphism and CRC risk. Therefore, the present study was performed using the already published
case–control reports to draw a reliable conclusion on the overall relationship of TNF-α –308 G>A (rs1800629) gene
polymorphism with CRC risk. Meta-analysis is a statistical tool that increases the statistical power and precision in
assessment of the effects by using the results of early reports and thus circumventing the issue of small sample size
and the insufficient statistical power of individual early genetic studies [30].
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of individuals was selected. Study was excluded based upon: (a) duplicate or overlapping report, (b) report based on
only CRC cases, (c) no reported genotype frequency and (d) the data of review or abstract.

Data extraction
The quality of the data extracted was assessed by two investigators (R.K.M. and M.A.K.) individually following a
standard protocol. Preset inclusion/exclusion as well as the sequential exclusion criteria of the unsuitable studies outlined in the data-collection form was strictly adhered to ensure the accuracy of the collected data. Any disagreement
between the investigators about the quality of collected data was first subjected to a consensus and then finally settled
with an open discussion with the arbitrator (S.H.). The data extracted from the retrieved publications consisted first
author name, the country of origin, year of publication, number and source of cases and controls, type of study type,
genotype frequencies and association with CRC.
Downloaded from http://portlandpress.com/bioscirep/article-pdf/39/1/BSR20181052/864007/bsr-2018-1052.pdf by guest on 11 March 2021

Quality assessment using Newcastle–Ottawa Scale
Quality assessment of the selected studies was done independently by two investigators, namely A.H. and N.A. This
evaluation was done by following the Newcastle–Ottawa Scale (NOS) of quality assessment [31]. The major aspects
used for NOS quality assessment criteria were: (a) selection of subjects: 0–4 points, (b) subject comparability: 0–2
points and (c) clinical outcome: 0–3 points. The extracted case–control studies securing 5 or more stars were considered having moderate to good quality [31,32]. In case, if any difference occurred on any item between the above two
investigators, the issue was fully discussed and solved by a detailed discussion in the presence of third investigator
(S.A.D.) participated as adjudicator.

Statistical analysis
Pooled ORs and their corresponding 95% CIs were used to appraise the risk association between the TNF-α –308
G>A gene polymorphism and susceptibility to CRC. Heterogeneity was assessed using the chi-square-based Q-test
and was considered significant if the P-value was less than 0.05 [33]. The collected data from single comparison was
calculated using a fixed effects model [34], in case of no heterogeneity. However, the random-effects model [35] was
employed for pooling of the data. Further, I 2 statistics used to estimate the interstudy variability in which larger values
showed a higher degree of heterogeneity [36]. Hardy–Weinberg equilibrium (HWE) in the controls was calculated
using chi-square test. Whereas Egger’s regression test showing the funnel plot asymmetry was used to measure significance of publication bias, if any. Further to this, ethnicity was adopted to perform the subgroup stratified analysis,
when data were available. The Comprehensive Meta-Analysis (CMA) software program Version 2.0 from Biostat
(NJ), U.S.A. was selected to conduct all the statistical calculations involved in the present meta-analysis.

Trial sequential analysis
According to the Cochrane handbook, the meta-analyses are acceptable if it includes all the eligible trials. However,
it may lack sufficient evidences. The meta-analysis may contain systematic errors (bias) or random errors (play of
chance), which can be reduced using novel statistical analysis program named ‘Trial Sequential Analysis’ (TSA) tool,
made by Copenhagen Trial Unit, Center for Clinical Intervention Research, Denmark). TSA calculates required information size as well as adjusts the threshold for the statistical significance and finally calculates the robustness of
present conclusion [37–39]. Briefly, a TSA monitoring boundary crossed with Z curve confirms the presence of robust
evidence. In such case further trials are not needed. However, Z curve not crossing the monitoring boundaries suggest that the trial should continue. Trial Sequential Analysis (version 0.9, http://www.ctu.dk/tsa/) was used in current
study.

Results
Literature search
Two investigators (viz. R.K.M. and M.A.K.) individually examined every title and abstract of the retrieved studies
using the designated online web-databases search in a sequential order. The full-text of each study apposite for the
inclusion was also recovered. To evaluate the aptness of the study for the inclusion in this pooled analysis, one researcher (R.K.M.) systematically examined all the full-text retrieved publications. Afterwards, the second researcher
(M.A.K.) performed the same procedure of text evaluation independently by selecting randomly 10% of the full-text
articles. During the study selection process, complete agreement was found between the above stated two researchers
regarding the study exclusion and selection criteria. After the selection of the final set of the eligible studies, another
researcher (S.A.D.) extrapolated the pertinent data from all the included studies. This step of data extrapolation was
c 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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meta-analysis

cross-checked by a fourth researcher (A.J.) independently by collecting the information from all the selected articles.
Discrepancies and discords occurred during the study selection were resolved amicably with thorough discussion
before the adjudicators (S.H. and B.N.M.).

Properties of the reports included in the present study
Fifteen articles were selected after systematic literature search done on PubMed, EMBASE and Google Scholar. The
retrieved texts were scrutinized by perusing complete texts for their potential relevance for the current meta-analysis
(Figure 1). Reports showing TNF-α gene polymorphism to estimate survival in CRC patients or using CRC variants
as indicators for prognosis were excluded at the onset. Likewise, the reports analyzing TNF mRNA levels or subsequent protein expression were also excluded. The studies with case–control or cohort that design only reporting
frequency of all the three genotypes were included for the current meta-analysis. Additionally, all the references cited
in the retrieved articles were also scanned to identify other potential case–control studies. Finally, the 15 original
publications were found eligible after applying the stringent inclusion and exclusion criteria (Table 1). The genotypes
distribution, P-values of HWE and susceptibility towards colorectal risk have been given in Table 2. The selected
studies (15 in number) were examined for the overall quality following the NOS. Maximum number of the studies
included (>80%) scored 5 stars or more, showing a modest to decent quality (Table 3).

Assessment of publication bias
Begg’s funnel plot and Egger’s test showed no publication bias among all the comparison models (Table 4) in every
genetic model and the allelic contrast (Figure 2).

Test of heterogeneity
The chi-squared-based Q-test and I 2 statistics showed the substantial amount of heterogeneity in all the genetic models leading to the use of random-effects model to process the data (Table 4).

Quantitative synthesis
All the 15 studies pooled together amounted to 3116 confirmed CRC cases and 4480 healthy controls for the evaluation of overall association between the TNF-α –308 G>A SNP and CRC risk. The overall ORs showed no statistically
significant association with high or low risk between TNF-α –308 G>A gene polymorphism and CRC risk in neither
genetic models (A vs. G: P = 0.524; OR = 1.074, 95% CI = 0.863–1.335), homozygous (AA vs. GG: P = 0.489; OR =
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Figure 1. PRISMA 2009 ﬂow diagram depicting identiﬁcation and selection process (inclusion/exclusion) of the germane
published articles dealing with TNF-α –308 G>A gene polymorphism and colorectal cancer (CRC) risk for the present
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Table 1 Main characteristics of all studies included in the present meta-analysis
First authors
and year

Country

Ethnicity

Control

Cases

Study

Methods

Association

Cho et al., 2017

Korea

Asian

1445

695

HB

Mass array

No risk

Gutiérrez et al.,
2016

Mexico

Caucasian

209

164

PB

PCR-RFLP

No risk

Banday et al., 2016

India

Asian

184

142

HB

PCR-RFLP

No risk

Hamadien et al.,
2016

Saudi

Asian

100

100

HB

TaqMan

Yes

Bulgaria

Caucasian

177

119

HB

PCR-RFLP

No

China

Asian

180

180

HB

PCR-RFLP

Yes

Stanilov et al., 2014
Li et al., 2011

USA

Caucasian

372

204

PB

Taqman

No

Garrity et al., 2008

USA

Caucasian

114

114

HB

Sequencing

Yes

Toth et al., 2007

Hungary

Caucasian

141

183

HB

PCR-RFLP

No

Gunter et al., 2006

USA

Caucasian

202

217

HB

Taqman

No

Theodoropoulos et
al., 2006

Greece

Caucasian

200

222

HB

PCR-RFLP

No

Scotland

Caucasian

389

246

PB

Taqman

No

Landi et al., 2003

Spain

Caucasian

326

377

HB

Sequencing

No

Jang et al., 2001

Korea

Asian

92

27

HB

PCR-RFLP

No

Park et al., 1998

Korea

Asian

328

140

HB

PCR-RFLP

No

Macarthur et al.,
2005

Downloaded from http://portlandpress.com/bioscirep/article-pdf/39/1/BSR20181052/864007/bsr-2018-1052.pdf by guest on 11 March 2021

Tsilidis et al., 2009

Abbreviations: HB, hospital based; PB, population based.

Table 2 Genotypic distribution of TNF-α –308 G>A (rs1800629) gene polymorphism included in this meta-analysis
Authors and
year
GG

Controls
Genotype
GA
AA

Minor allele
MAF

GG

Cases
Genotype
GA

AA

Minor allele
MAF

HWE
P-value

Cho et al.,
2017

1192

203

50

0.104

598

90

7

0.074

0.001

Gutiérrez et al.,
2016

180

27

2

0.074

139

21

4

0.088

0.391

Banday et al.,
2016

150

34

0

0.092

124

18

0

0.063

0.167

Hamadien et
al., 2016

59

23

18

0.295

67

23

10

0.215

0.001

Stanilov et al.,
2014

135

40

2

0.124

88

28

3

0.142

0.612

Li et al., 2011

160

19

1

0.058

156

15

9

0.091

0.599

Tsilidis et al.,
2009

275

90

7

0.139

146

55

3

0.149

0.908

Garrity et al.,
2008

92

20

2

0.105

52

49

13

0.328

0.464

Toth et al.,
2007

111

30

0

0.106

132

48

3

0.147

0.157

Gunter et al.,
2006

139

57

6

0.170

146

59

12

0.191

0.957

146

44

10

0.16

152

56

14

0.189

0.010

Macarthur et
al., 2005

224

145

20

0.237

157

74

15

0.211

0.577

Landi et al.,
2003

234

76

10

0.15

278

80

5

0.123

0.219

Jang et al.,
2001

85

7

0

0.038

24

3

0

0.055

0.704

Park et al.,
1998

252

72

4

0.121

115

24

1

0.092

0.651

Theodoropoulos
et al., 2006

Abbreviations: HWE, Hardy–Weinberg equilibrium; MAF, minor allele frequency.
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Figure 2. Assessment of publication bias shown with Funnel plots in studies assaying odds of CRC risk associated with

the TNF-α –308 G>A polymorphism for the overall analysis (odds ratio against standard error in different genetic models)
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Table 3 Quality assessment conducted according to the Newcastle–Ottawa Scale for all the studies included in this
meta-analysis
First author and year

Quality indicators
Comparability

Selection

Exposure

***

*

**

Gutiérrez et al., 2016

***

*

**

Banday et al., 2016

***

*

***

Hamadien et al., 2016

**

*

**

Stanilov et al., 2014

***

*

**

Li et al., 2011

**

*

**

Tsilidis et al., 2009

***

**

**

Garrity et al., 2008

**

**

**

Toth et al., 2007

***

*

**

Gunter et al., 2006

***

**

**

Theodoropoulos et al., 2006

**

*

**

Macarthur et al., 2005

***

*

**

Landi et al., 2003

**

**

**

Jang et al., 2001

**

*

**

Park et al., 1998

**

*

**

Note: On assessing the quality of the included studies using the Newcastle–Ottawa Scale, all the studies scored ﬁve stars or more which indicates no
bias.

Table 4 Statistics to test publication bias and heterogeneity in this meta-analysis of TNF-α –308 G>A polymorphism and
CRC risk: overall

Comparisons

Model used for
the
meta-analysis

Egger’s regression analysis
95%
conﬁdence
Intercept
interval
P-value

Heterogeneity analysis

Q-value

Pheterogeneity

I2 (%)

A vs. G

2.67

−0.49 to 5.84

0.09

58.67

0.01

76.14

Random

AA vs. GG

2.24

−0.19 to 4.69

0.07

34.99

0.01

65.71

Random

AG vs. GG

1.35

−1.20 to 3.89

0.27

32.60

0.01

57.06

Random

AA+AG vs. GG

2.21

−0.66 to 5.09

0.12

45.27

0.01

69.07

Random

AA vs. AG+GG

2.02

−0.29 to 4.35

0.08

31.27

0.01

61.63

Random

1.227, 95% CI = 0.688–2.188), heterozygous (AG vs. GG: P = 0.811; OR = 1.024, 95% CI = 0.843–1.244), dominant
(AA+AG vs. GG: P = 0.630; OR = 1.055, 95% CI = 0.849–1.311) and recessive (AA vs. AG+GG: P = 0.549; OR =
1.181, 95% CI = 0.686–2.033) genetic models (Figure 3).

Sensitivity analysis
Sensitivity analysis used to evaluate the impact of each individual study on the pooled ORs revealed no significant
influence on the pooled OR by any individual study (Figure 4).

Subgroup analysis: association of the TNF-α –308 G>A SNP and risk of
CRC in Caucasian and Asian population
A stratified subgroup analysis based on the ethnicity of the enrolled subjects was performed to explore the effect of
ethnicity (Caucasian and Asian) on the association of TNF-α –308 G>A SNP and the risk of CRC onset.

Subgroup analysis of Caucasian population
Nine case–control studies contain 2130 controls and 1846 cases. These controls and cases were included for subgroup
analysis of Caucasian population. The analysis showed significant heterogeneity in three genetic models (Table 5)
(Supplementary Figure S1). The conducted analyses using random and fixed models observed no significant association of CRC susceptibility in all the genetic models, i.e. allele model (A vs. G: P = 0.121; OR = 1.238, 95% CI =
c 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution

License 4.0 (CC BY).
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Figure 3. Forest plot of ORs with 95% CI of CRC risk associated with the TNF-α –308 G>A gene polymorphism for the
overall population

Note: Black square represents the value of OR and the size of the square indicates the inverse proportion relative to its variance.
Horizontal line is the 95% CI of OR.
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Figure 4. Sensitivity analysis of TNF-α –308 G>A polymorphism with overall CRC risk to evaluate the inﬂuence of each
individual study on the pooled OR by deleting one single study each time for the overall analysis (for all the genetic models)

Note: Black square represents the value of OR and the size of the square indicates the inverse proportion relative to its variance.
Horizontal line is the 95% CI of OR.
c 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution

License 4.0 (CC BY).
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Table 5 Statistics to test publication bias and heterogeneity in this meta-analysis of TNF-α –308 G>A polymorphism and
CRC risk: Caucasian ethnicity population

Comparisons

Egger’s regression analysis
95%
conﬁdence
Intercept
interval
P-value

Model used for
the
meta-analysis

Heterogeneity analysis

Q-value

Pheterogeneity

I2 (%)

A vs. G

6.43

0.80 to 12.06

0.03

35.67

0.01

77.57

AA vs. GG

1.71

−1.06 to 4.49

0.18

15.22

0.06

47.43

Random
Fixed

AG vs. GG

5.86

0.38 to 11.33

0.04

26.65

0.01

69.98

Random

6.93

1.23 to 12.63

0.02

33.29

0.01

75.97

Random

AA vs. AG+GG

1.39

−1.09 to 3.87

0.22

11.89

0.16

32.69

Fixed

Table 6 Statistics to test publication bias and heterogeneity in this meta-analysis of TNF-α –308 G>A polymorphism and
CRC risk: Asian ethnicity population

Comparisons

Egger’s regression analysis
95%
Conﬁdence
Intercept
Interval
p-value

Model used for
the
meta-analysis

Heterogeneity analysis

Q-value

Pheterogeneity

I2 (%)

A vs. G

1.45

−1.75 to 4.65

0.28

9.09

0.10

45.04

Fixed

AA vs. GG

2.77

−5.10 to 10.65

0.27

9.56

0.02

68.61

Random

AG vs. GG

0.00

−1.67 to 1.67

0.99

1.85

0.87

0.01

Fixed

AA+AG vs. GG

0.71

−1.38 to 2.80

0.39

3.45

0.63

0.01

Fixed

AA vs. AG+GG

2.76

−5.10 to 10.62

0.27

9.61

0.02

68.79

Random

0.945–1.622), homozygous model (AA vs. GG: P = 0.108; OR = 1.363, 95% CI = 0.934–1.989), heterozygous model
(AG vs. GG: P = 0.284; OR = 1.165, 95% CI = 0.881–1.540), dominant model (AA+AG vs. GG: P = 0.182; OR =
1.225, 95% CI = 0.909–1.651) and recessive model (AA vs. AG+GG: P = 0.112; OR = 1.355, 95% CI = 0.932–1.971)
(Figure 5). Results of the sensitivity analysis are shown as Supplementary Figure S2.

Subgroup analysis of Asian population
Like Caucasian population, six studies having 2329 controls and 1284 cases were included in the subgroup analysis
of Asian population. The analysis showed no publication bias but heterogeneity was observed in two genetic models
(Table 6) (Supplementary Figure S3). Interestingly, the protective association of CRC risk with allelic contrast (A vs.
G: P = 0.001; OR = 0.753, 95% CI = 0.635–0.893) and dominant genetic model (AA+AG vs. GG: P = 0.010; OR
= 0.781, 95% CI = 0.647–0.943). The remaining three genetic models, i.e. homozygous (AA vs. GG: P = 0.507; OR
= 0.682, 95% CI = 0.220–2.116), heterozygous (AG vs. GG: P = 0.073; OR = 0.833, 95% CI = 0.682–1.017) and
recessive (AA vs. AG+GG: P = 0.537; OR = 0.701, 95% CI = 0.227–2.162) genetic models showed no link with high
or low risk of CRC (Figure 6). Sensitivity analysis results are supplied as the Supplementary Figure S4.

Trial sequential analysis of TNF-α –308 G>A SNP and risk of CRC
TSA (taking the data of the dominant model) was used for the current analysis to check if further trials are required
(Figure 7A). Same result was observed after the subgroup analysis based on the Caucasian (Figure 7B) and Asian
(Figure 7C) population.

Discussion
The SNP analysis is useful in genomic DNA screening. It is specifically important in case of CRC because these
markers are not affected by disease activity and remain unchanged over time. Research probing genetic associations
are powerful methods for identifying low penetrance susceptibility genes that can affect biological process and provide
linkage analysis when investigating complex disease like CRC. Translating this information into routinely applied
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Figure 5. Forest plot of ORs with 95% CI of CRC risk associated with the TNF-α –308 G>A gene polymorphism for the
Caucasian population

Note: Black square represents the value of OR and the size of the square indicates the inverse proportion relative to its variance.
Horizontal line is the 95% CI of OR.
c 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution

License 4.0 (CC BY).
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Figure 6. Forest plot of ORs with 95% CI of CRC risk associated with the TNF-α –308 G>A gene polymorphism for the Asian
population
Note: Black square represents the value of OR and the size of the square indicates the inverse proportion relative to its variance.

Horizontal line is the 95% CI of OR.
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Figure 7. Trial sequence analysis of all the included studies dealing with TNF-α –308 G>A gene polymorphisms based on

dominant genetic model for (A) Overall, (B) Caucasian, and (C) Asian ethnicity population and CRC risk

c 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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diagnostics would assist in better understanding of the CRC etiology, possibly leading to novel and better clinical
practice with many benefits for the patient.
Inflammatory response harmonizes host response against infection participating in repair of tissue, in case of tissue
damage. A chronic inflammation many a time alters the immune system and leads to carcinogenesis [40]. Over the
time, the cytokines are receiving overdue attention due to their property of mediating and regulating the immune
response including inflammation. The cytokines may regulate the pro-inflammatory and anti-inflammatory network
to stimulate signaling pathways involved in malignancy development [41].
CRC onset and progression is linked with innate immune processes and inflammation in intestine. Pro- inflammatory genes have key role in maintenance and growth of CRC [42]. TNF-α is a pro-inflammatory cytokine made
by activated immune cells leading to suppression of tumor proliferation [43]. TNF-α also activates antitumor the
natural killer cells and CD8 T cells [44].
CRC onset and tumor progression are preceded by inflammation. This has developed a curiosity in scientific community to understand the molecular signaling pathways that connect TNF-α with the development and survival of
CRC tumor cells. The expression of TNF-α like other cytokines is tightly regulated at the transcriptional level and
also at post-transcriptional level. The –308 G>A SNP is located inside the regulatory regions of TNF-α gene. TNF-α
expression and secretion both are influenced by this polymorphism.
Many scientists have published their works on CRC, but the molecular and biological mechanism of relationship
between TNF-α gene polymorphism and risk of CRC is not completely understood. Till date, the reports of TNF-α
(–308 G>A) SNP in relation with CRC risk lack consensus. Many clinical case–control studies have reported both
positive as well as negative association of CRC and TNF-α (–308 G>A) SNP. Hence, larger sample size with pooled
and subgroup analysis is demand of the time to evaluate the potential role of TNF-α –308 G>A polymorphism as
a genetic risk factor for CRC infection. The combined ORs from many early reports that lead to large sample size
with required statistical robustness also lower the random errors [45]. The meta-analyses address a wide variety of
clinical problems using early published data. This meta-analysis included 15 eligible case–control studies comprising
3116 cases and 4480 healthy controls and analyzed the pooled ORs and P-value to appraise the precise relationship
between the TNF-α –308 G>A SNP and CRC risk. NOS quality assessment showed nearly every study scoring five
or more than five stars suggesting good to moderate quality of extracted data. The current meta-analysis shows no
link between the TNF-α –308 G>A SNP and CRC susceptibility by any genetic model in overall population analysis.
The speculations based upon the findings tell that numerous polymorphic sites present in the promoter and the
coding regions of TNF-α gene might serve to keep this gene under tight control and influence the expression of
TNF-α. Hence, the haplotype combinations might be conserved in certain population to protect against pathogens.
Furthermore, the gene reporter assay also testified that A allele of –308 polymorphism does not influence TNF-α
gene transcription [46]. Many early reports show that –308 G>A polymorphism leads to different transcription rate
in TNF-α production [47,48].
A stratification analysis of ethnicity was performed considering the fact that polymorphism frequencies might differ among ethnic groups. The separate race-specific meta-analysis done in Caucasian and Asian populations show
that TNF-α –308G>A SNP is protective against the CRC risk in Asian but not in Caucasians population. The increased plasma concentration of TNF-α, which is a result of single TNF-α –308 A allele, might not influence CRC
risk. The most likely reason might be the population stratification within involved studies, especially when both allelic frequencies and incidence of disease vary across ethnic groups. The range of A allele frequency is from 2 to 9%
in Asians, 8 to 10% in South Americans and 10 to 23% in Europeans.
An early meta-analysis by Min et al. showed increased risk of CRC [49]. But, they found increased risk with only
homozygous model and less significant risk under heterozygote model in overall population. Furthermore, they have
not provided the frequencies of each genotype of included studies and any risk involved in the subgroup analysis.
After applying the stern inclusion criteria, the current meta-analysis was added new studies that led to increase in
the number of included subjects in both CRC and controls. The analysis was also stratified along race namely Asian
and Caucasian. The results of the current analysis tend to be more precise in estimating the relationship between the
TNF-α –308 G>A SNP and risk of CRC in overall population as well as ethnicity than previous ones.
The previous findings suggested that susceptibility towards CRC is polygenic in nature that indicates the possibility
that many genes are participate in determining the resistance or susceptibility to CRC. Consequently, the complex
nature of CRC and multifaceted nature of the immune system, TNF-α –308 G>A SNP is not the sole reason for the
predisposition to CRC, but this polymorphism may interact with other polymorphisms present in linkage disequilibrium of this gene to cause risk.
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Despite being many advantages of the present aforementioned study, some limitations must also be mentioned,
namely: first, interstudy heterogeneity was observed in the overall comparison from each genetic model. We minimized the likelihood of this problem by performing data analysis by using random-effects model. When studies were
stratified by ethnicity, low heterogeneity was found in both Caucasian and Asian populations. Hence, we considered
that the racial differences and ethnic origin of the study population, inadequate selection criteria of the subjects, and
small sample size of each included study might be responsible for the foremost source of heterogeneity. Second, the
present study included the reports published in the English language only. Further, PubMed-Medline, EMBASE and
Google Scholar electronic databases were used for the study and subsequent data retrieval. It is possible that some
relevant studies published in language other than English or indexed on different databases, are not included. Third,
the present study did not have any information on gene–environment interactions due to inadequate data available
on this matter. Fourth, the calculations used unadjusted assessment of ORs, which may influence the results.
Despite above limitations, the present study does have many strengths: First, it has included large number of subjects that gave powerful evidence to reach on precise and robust conclusion. It would greatly improve the understanding on the role TNF-α –308 G>A SNP in CRC pathogenesis. Second, absence of publication bias and sensitivity
analysis suggests the reliability of the results and whole study. Furthermore, all the included studies were of good to
modest quality to fulfill the preset needful criteria required by NOS quality assessment.

Conclusions
The current meta-analysis indicates that TNF-α –308 G>A SNP has no role in CRC progression. It also suggests that
individuals with TNF-α –308 G>A genetic variant have comparatively less CRC risk among Asians. It is a suggestive
limited piece of evidence that –308 A allele might reduce CRC risk. As, TNF-α plays a significant role in immune
response, further larger case–control studies are warranted to make the conclusions more comprehensive. Taken as
a whole, the present study would greatly help the scientists in understanding the relationship of TNF-α –308 G>A
SNP and CRC risk across the world.
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